Literature DB >> 2551150

Fish oil diet rich in eicosapentaenoic acid increases bleeding time in the rat by interaction with sympathetic transmitters.

H Juan1, W Sametz.   

Abstract

The influence of a diet supplemented with MaxEPA (a fish oil concentrate, rich in eicosapentaenoic acid = EPA) on bleeding time in small mesenteric arteries of the rat and on formation of thromboxane B2 (TXB2) by ADP-stimulated platelets was investigated. Since EPA has been found to antagonize noradrenaline (NA) - induced vasoconstriction, the influences on bleeding time of the alpha-receptor antagonist phentolamine and of the adrenergic neuron blocking agent guanethidine alone as well as during dietary supplementation with MaxEPA were studied. Bleeding time slowly increased during the MaxEPA diet over a period of 12 weeks resulting in a final prolongation of about 75%. Indomethacin which dose-dependently increased bleeding time in control rats, further increased the already prolonged bleeding time in rats on the MaxEPA diet. Guanethidine prolonged bleeding time strongly in control animals but caused no further increase in those on the MaxEPA diet. Indomethacin also further increased the bleeding time prolonged by guanethidine, just as it did in animals on MaxEPA diet. In contrast to guanethidine, phentolamine prolonged bleeding time only slightly. The ability of platelets from rats on the diet to generate TXB2 was reduced to 59.5% but was more drastically reduced (to 26.7%) from rats pretreated with indomethacin. The results indicate that MaxEPA feeding prolongs bleeding time by a mechanism other than that of indomethacin. We speculate that EPA prolongs bleeding time rather by antagonizing the vasoconstrictor effect of sympathetic transmitters at the site of the injured vessel than by a reduced formation of TXA2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551150     DOI: 10.1007/BF02022993

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  25 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.

Authors:  J M Lundberg; K Tatemoto
Journal:  Acta Physiol Scand       Date:  1982-12

3.  Delay in primary haemostasis produced by a fish diet without change in local thromboxane A2.

Authors:  M Thorngren; S Shafi; G V Born
Journal:  Br J Haematol       Date:  1984-12       Impact factor: 6.998

4.  Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation.

Authors:  M Thorngren; A Gustafson
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

5.  Platelet - vessel wall interaction: influence of diet.

Authors:  J Dyerberg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1981-08-18       Impact factor: 6.237

6.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

7.  Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid.

Authors:  M Thorngren; S Shafi; G V Born
Journal:  Lancet       Date:  1983-05-14       Impact factor: 79.321

8.  Haemostatic function and platelet polyunsaturated fatty acids in Eskimos.

Authors:  J Dyerberg; H O Bang
Journal:  Lancet       Date:  1979-09-01       Impact factor: 79.321

9.  Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3).

Authors:  S Fischer; P C Weber
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

10.  Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet.

Authors:  W Siess; P Roth; B Scherer; I Kurzmann; B Böhlig; P C Weber
Journal:  Lancet       Date:  1980-03-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.